Mice treated with RNase A exhibited moderately but significantly attenuated AAA progression compared to PBS-treated controls (final aortic volume growth: 291 ± 59% vs. 340 ± 55%; p = 0.039). This evidence concerns the gene RNASE1 and triple-A syndrome.